During the past decade, Sutter Cancer Centers Radiation Oncology Services-Auburn conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 65 clinical trials were completed, i.e. on average, 89% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 46 clinical trials were completed. i.e. 287.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Auburn" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Radiation Therapy Oncology Group" with 26 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "NRG Oncology" with 14 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Cancer Centers Radiation Oncology Services-Auburn" #1 collaborator was "National Cancer Institute (NCI)" with 81 trials as a collaborator, "NRG Oncology" with 46 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Cancer Centers Radiation Oncology Services-Auburn" are "Prostate Cancer" (10 trials), "Head and Neck Cancer" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Recurrent Squamous Cell Lung Carcinoma" (6 trials). Many other conditions were trialed in "Sutter Cancer Centers Radiation Oncology Services-Auburn" in a lesser frequency.

Most popular intervention types in "Sutter Cancer Centers Radiation Oncology Services-Auburn" are "Drug" (105 trials), "Other" (76 trials), "Radiation" (56 trials), "Biological" (52 trials) and "Procedure" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (33 trials), "Paclitaxel" (18 trials), "Carboplatin" (16 trials) and "Cisplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Cancer Centers Radiation Oncology Services-Auburn" are 95 trials for "All" genders, 30 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Cancer Centers Radiation Oncology Services-Auburn". undefined are not yet recruiting, 23 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Sutter Cancer Centers Radiation Oncology Services-Auburn, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Cancer Centers Radiation Oncology Services-Auburn, 3 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".